David Finkle

1.8k total citations
7 papers, 390 citations indexed

About

David Finkle is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, David Finkle has authored 7 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in David Finkle's work include Monoclonal and Polyclonal Antibodies Research (2 papers), Vascular Tumors and Angiosarcomas (1 paper) and RNA modifications and cancer (1 paper). David Finkle is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (2 papers), Vascular Tumors and Angiosarcomas (1 paper) and RNA modifications and cancer (1 paper). David Finkle collaborates with scholars based in United States, France and Japan. David Finkle's co-authors include Franklin Peale, Rayna Venook, Elaine Mai, Thijs J. Hagenbeek, Matthew J. Brauer, Xiumin Wu, Philip G. Hollingshead, Hai Ngu, Napoleone Ferrara and Dorothy French and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Clinical Cancer Research.

In The Last Decade

David Finkle

7 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Finkle United States 7 218 161 73 72 67 7 390
Akira Nagabukuro Japan 8 267 1.2× 91 0.6× 35 0.5× 119 1.7× 31 0.5× 12 458
Hong Seo Choi South Korea 12 272 1.2× 86 0.5× 49 0.7× 60 0.8× 21 0.3× 24 422
Andrew Chen United States 5 203 0.9× 72 0.4× 98 1.3× 66 0.9× 47 0.7× 6 465
GuoGuang Ying United States 12 261 1.2× 84 0.5× 34 0.5× 67 0.9× 27 0.4× 12 398
Christopher S. Bland United States 5 578 2.7× 105 0.7× 93 1.3× 65 0.9× 13 0.2× 5 728
Maurizio Fazio United States 11 433 2.0× 124 0.8× 106 1.5× 54 0.8× 85 1.3× 16 703
Erik S. Anderson United States 10 302 1.4× 135 0.8× 64 0.9× 31 0.4× 27 0.4× 26 585
Lidija Pestic‐Dragovich United States 7 375 1.7× 90 0.6× 39 0.5× 44 0.6× 21 0.3× 8 558
Christa L. Brown United States 6 303 1.4× 142 0.9× 52 0.7× 28 0.4× 62 0.9× 7 524
Pournima Kadam United States 11 211 1.0× 218 1.4× 103 1.4× 150 2.1× 13 0.2× 16 502

Countries citing papers authored by David Finkle

Since Specialization
Citations

This map shows the geographic impact of David Finkle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Finkle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Finkle more than expected).

Fields of papers citing papers by David Finkle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Finkle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Finkle. The network helps show where David Finkle may publish in the future.

Co-authorship network of co-authors of David Finkle

This figure shows the co-authorship network connecting the top 25 collaborators of David Finkle. A scholar is included among the top collaborators of David Finkle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Finkle. David Finkle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Hilton, Hugo G., Nimrod D. Rubinstein, Andrea Ireland, et al.. (2019). Single-cell transcriptomics of the naked mole-rat reveals unexpected features of mammalian immunity. PLoS Biology. 17(11). e3000528–e3000528. 76 indexed citations
2.
Choy, Lisa, Thijs J. Hagenbeek, Margaret Solon, et al.. (2017). Constitutive NOTCH3 Signaling Promotes the Growth of Basal Breast Cancers. Cancer Research. 77(6). 1439–1452. 73 indexed citations
3.
Bisconte, Angelina, Ronald J. Hill, Michael Bradshaw, et al.. (2015). Efficacy in collagen induced arthritis models with a selective, reversible covalent Bruton’s tyrosine kinase inhibitor PRN473 is driven by durable target occupancy rather than extended plasma exposure (THER5P.904). The Journal of Immunology. 194(1_Supplement). 139.6–139.6. 6 indexed citations
4.
Shi, Yunzhou, Jason Oeh, Jeffrey Eastham‐Anderson, et al.. (2013). Mapping In Vivo Tumor Oxygenation within Viable Tumor by 19F-MRI and Multispectral Analysis. Neoplasia. 15(11). 1241–IN1. 17 indexed citations
5.
Chung, Alicia S., Marcin Kowanetz, Xiumin Wu, et al.. (2012). Differential drug class‐specific metastatic effects following treatment with a panel of angiogenesis inhibitors. The Journal of Pathology. 227(4). 404–416. 71 indexed citations
6.
Finkle, David, Vida Asghari, Elaine Mai, et al.. (2004). HER2-Targeted Therapy Reduces Incidence and Progression of Midlife Mammary Tumors in Female Murine Mammary Tumor Virus huHER2-Transgenic Mice. Clinical Cancer Research. 10(7). 2499–2511. 91 indexed citations
7.
Jin, Hongkui, Renhui Yang, Gilbert A. Keller, et al.. (1996). IN VIVO EFFECTS OF CARDIOTROPHIN-1. Cytokine. 8(12). 920–926. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026